References
- Behar E, Chao NJ, Hiraki DD, et al. Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease. N Engl J Med 1996;334(5):286–291.
- Nichlos WC, Antin JH, Lunetta KL,, et al. Polymorphism of adhesion molecule CD31 is not a significant risk factor for graft-versus host disease. Blood 1996;88(12):4429–4434.
- Tseng LH, Lin MT, Hansen JA, et al. Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation. Blood 1999;94:2911.
- Gallardo D, Arostegui JI, Balas A, et al. Disparity for the minor histocompatibility antigens HA-1 is associated with an increased risk of acute graft-versus-host disease but it does not affect chronic GVHD incidence, disease-free survival or overall survival after allogeneic human leukocyte antigen-identical sibling donor transplantation, Br J Haematol 2001;114: 931.
- van Els CA, D’amaro J, Pool J, et al. Immunogenetics of human minor histocompatibility antigens: Their polymorph-ism and immunodominance. Immunogentics 1992;35:161.
- Grumet FC, Hiraki DD, Brown BW, et al. CD31 mismatching affects marrow transplantation outcome. Biol Blood Marrow Transplant 2001;7:503–512.
- Maruya E, Saji H, Seki S, et al. Evidence that Cd3 1, Cd49b, and CD621 are immunodominant minor histocompatibility antigens in HLA identical sibling bone marrow transplants. Blood 1998;92:2169.
- Rozman P, Karas M, Kosir A, et al. Are human platelet alloantigens (HPA) minor transplantation antigens in clinical bone marrow transplantation? Bone marrow Trans-plantation 2003;31:497.
- Heinemann FM, Ferencik S, Ottinger HD, et al. Impact of Disparity of minor histocompatibility antigens HA-1, CD31 and Cd49b in hematopoeitic stem cell transplantation of patients with chronic myeloid leukemia with sibling and unrelated donors. Transplantation 2004;77(7):1103–1106.
- Parkhill J, Wren BW, Mungall K, et al. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 2000;403:665–668.
- Sullivan K. Graft-versus-host disease. In: Forman SJ, Blume KG, Thomas ED, editors. Bone marrow transplantation. Oxford, UK: Blackwell Scientific Publications; 1994. p 339–362.
- Warren EH, Greenberg PD, Riddel SR. Cytotoxic T-lympho-cyte-defined human minor histocompatibility antigens with a restricted tissue distribution. Blood 1998;91: 2197–2207.
- Wang W, Meadows LR, den Haan JM, et al. Human H-Y: A male-specific histocompatibility antigen derived from the SMCY protein. Science 1995;269:1588–1590.
- Goulmy E, Schipper R, Pool J, et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 1996;334:281–285.
- Cavanagh G, Chapman CE, Carter V, et al. Donor CD31 genotype impacts on transplant complications after human leukocyte antigen matched sibling allogeneic bone marrow transplantation. Transplantation 2005;15(79(5)):602–605.
- DaCosta L, Charron D, Loiseau P. Does the adhesion molecule CD31 act as a minor histocompatibility antigen? Blood 1997;90: 1332.
- Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18(4):295.
- Balduinin CL, Noris P, Giorgiani G, et al. Incompatibility for CD31 and human platelet antigens and acute graft-versus-host disease after bone marrow transplantation. Br J Haematol 1999;106:723–729.
- Vicini G, Masset M, Semana G, Vernant JP. A human minor histocompatibility antigen which appears to segregate with the major histocompatibility complex. Transplantation 1994;58:361–367.
- den Haan JMIVI, Sherman NE, Blokland E, Huczko E, Koning F, Drijfhout JW, Skipper J, Shabanowitz J, Hunt DF, Engelhard VH, Goulmy E. Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science 1995;268:1476.
- DeLisser HM, Newman PJ, Albelda SM. Molecular and functional aspects of PECANI-1/CD31. Immunol Today 1994;15: 490.
- Zehnder JL, Shatsky M, Leung LLK, Butcher EC, McGregor JL, Levitt U. Involvement of CD31 in lymphocyte-mediated immune responses: Importance of the membrane-proximal